Normothermic ex vivo kidney perfusion preserves mitochondrial and graft function after warm ischemia and is further enhanced by AP39 - Nature.com 常溫體外腎臟灌注在暖缺血後能保護線粒體和移植功能,並且在AP39的作用下進一步增強。
MiR-199a-5p aggravates against renal ischemia-reperfusion and transplant injury by targeting AKAP1 to disrupt mitochondrial dynamics.
MiR-199a-5p 透過靶向 AKAP1 來破壞線粒體動態,加劇腎臟缺血再灌注及移植損傷。
Am J Physiol Renal Physiol 2024-09-12
Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial.
心臟移植中供體心臟的低溫氧合灌注:來自一項隨機、對照、開放標籤、多中心臨床試驗的短期結果。
Lancet 2024-08-17
Deceased donor kidney function and branched chain amino acid metabolism during ex vivo normothermic perfusion.
死者捐贈腎臟功能與體外常溫灌注期間的支鏈氨基酸代謝。
Kidney Int 2024-07-29
Salvaging donated kidneys from prolonged warm ischemia during ex vivo hypothermic oxygenated perfusion.
在體外低溫氧合灌流期間挽救因長時間溫熱缺血而捐贈的腎臟。
Kidney Int 2024-05-24
Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion.
抑制丙酮酸脫氫酶激酶4可改善腎臟缺血再灌注損傷,透過減少缺血期間的琥珀酸積聚並在再灌注期間保護粒線體功能。
Kidney Int 2023-09-25